SMAC, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA.
SMAC, Genentech Inc., 1 DNA Way, South San Francisco, CA, USA.
J Pharm Biomed Anal. 2021 Feb 5;194:113796. doi: 10.1016/j.jpba.2020.113796. Epub 2020 Nov 25.
In the pharmaceutical industry, an array of analytical testing is performed to demonstrate the safety and efficacy of drug substance and drug products. Among the most critical attributes of release testing are quantitation of residual solvents from the manufacturing process, which pose toxicity concerns, and determination of water content, which can impact potency and shelf life. Residual solvent determination in pharmaceuticals is most commonly performed using headspace capillary gas chromatography (GC) with flame ionization detection (FID), a robust technique that incorporates a mode of detection noteworthy for its sensitivity and wide dynamic range. However, FID responds exclusively to combustible organic species, and does not produce any signal for common gases such as carbon dioxide, ammonia, and notably water. While thermal conductivity detection (TCD) is an alternate, universal mode of detection that has a known response to all GC-appropriate compounds, including water, its use among pharmaceutical companies is uncommon due to the ubiquity of the more sensitive FID and the availability of other techniques for water quantitation such as Karl Fischer titrations (KF). In this work, the use of headspace GC-TCD was successfully demonstrated for the development of a 7.5-minute method for simultaneous quantitation of water, over 25 common residual solvents, and other volatile impurities in small molecule pharmaceutical samples. By carefully controlling sample preparation to minimize the impact of residual water from the diluent, the results for residual solvents and water obtained by this technique were found to be comparable to those of GC-FID and KF, respectively. Headspace GC-TCD improves the throughput of drug testing by greatly reducing the need for KF testing and associated expensive reagents, and helps to conserve samples that are often limited in early stages of development. The technique has desired sensitivity, precision, accuracy and linear dynamic range suitable for pharmaceutical analysis.
在制药行业中,进行了一系列的分析测试,以证明药物物质和药物产品的安全性和有效性。在放行测试中最关键的属性之一是定量残留溶剂,因为残留溶剂可能具有毒性,还需要测定水含量,因为水含量会影响药物的效力和保质期。药品中残留溶剂的测定最常采用顶空毛细管气相色谱(GC)与火焰离子化检测(FID)联用的方法,该方法具有强大的技术,其检测模式以灵敏度和宽动态范围而著称。然而,FID 仅对可燃有机物质产生响应,对于常见气体如二氧化碳、氨,尤其是水,不会产生任何信号。虽然热导检测(TCD)是一种替代的、通用的检测模式,对所有适合 GC 的化合物,包括水,都有已知的响应,但由于更敏感的 FID 的普遍性以及其他水定量技术如卡尔费休滴定(KF)的可用性,TCD 在制药公司中的应用并不常见。在这项工作中,成功地展示了使用顶空 GC-TCD 来开发一种 7.5 分钟的方法,用于同时定量小分子药物样品中的水、超过 25 种常见残留溶剂和其他挥发性杂质。通过仔细控制样品制备,以最大程度地减少稀释剂中残留水的影响,发现该技术测定残留溶剂和水的结果分别与 GC-FID 和 KF 的结果相当。顶空 GC-TCD 通过大大减少对 KF 测试和相关昂贵试剂的需求,提高了药物测试的通量,并有助于保存在开发早期通常有限的样品。该技术具有适合药物分析的所需灵敏度、精密度、准确度和线性动态范围。